Laidlaw Wealth Management LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1800608
NEW YORK CITY, NY
Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$362,090
+$132,827 QoQ
Shares Held
2,866
+74.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#1,556
of 2,275 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Laidlaw Wealth Management LLC holds $1,623,890 across 2 Drug Manufacturers - General names. GILD ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,052 | $1,261,800 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
2,866 | $362,090 |
All Filings in GILD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $362,090 | 2,866 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $229,263 | 1,645 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $234,187 | 1,908 | Shares | Sole | 2026-02-17 | |
| 2023-12-31 | $272,922 | 3,369 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $245,353 | 3,274 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $243,464 | 3,159 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $327,482 | 3,947 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $353,959 | 4,123 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $274,952 | 4,457 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $303,672 | 4,913 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $289,521 | 4,870 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $344,098 | 4,739 | Shares | Sole | 2022-02-14 | |
| 2020-12-31 | $215,154 | 3,693 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $260,912 | 3,490 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||